The nation of Zimbabwe has turned down a substantial US health deal valued at $367m (£272m) over five years because of the United States' insistence on sensitive data.
This rejection was revealed following a official document from December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government representative later stated that the US was demanding access to biological samples for research and commercial purposes while refused to share the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has called for continued talks to find a agreement suitable to both sides so the nation's critical HIV programme can be sustained.
Wider Background
This rejection comes after a comparable case in neighbouring Kenya, where a court suspended a related deal with the US following concerns were filed about the security of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and accountability.
Based on statements, Sixteen nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Effectively, our country would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens should a future health crisis emerge."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining structures previously set up through the international organization.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to manage potential global health emergencies.
"This system is designed to ensure that when a country contributes its samples, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome continued dialogue with our American counterparts on how future collaboration might be structured in a way that honours the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that negotiations should continue since much of the country's HIV programmes were funded by foreign aid.
"If specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
The halted deal emphasises the ongoing debate between receiving crucial international aid and safeguarding local interests in an increasingly interconnected world.